Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation

Vaccine

Volumn 29, Issue 4, 2011, Pages 855-862

  Li, Yaoming ^a   Ye, Jing ^a   Yang, Xiaohong ^a   Xu, Min ^a   Chen, Long ^a   Mei, Li ^a   Zhu, Jinghui ^a   Liu, Xueqin ^a   Chen, Huanchun ^a   Cao, Shengbo ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Dendritic cells (DCs); Japanese encephalitis virus (JEV); SA14 14 2 strain

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; INTERLEUKIN 6; JAPANESE ENCEPHALITIS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FOXA3 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL EXPANSION; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DRUG MECHANISM; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNOMODULATION; IMMUNOSTIMULATION; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; CHEMISTRY; GENE EXPRESSION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SECRETION; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIGENS, CD; CYTOKINES; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENZYME-LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 79951720683     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.108     Document Type: Article

References (48)

1. Vaughn D.W., Hoke C.H. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 1992, 14:197-221.
2. World Health Organization Japanese encephalitis vaccines. Wkly Epidemiol Rec 1998, 73:334-344.
3. Hanna J.N., Ritchie S.A., Phillips D.A., Shield J., Bailey M.C., Mackenzie J.S., et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996, 165:256-260.
4. Sugamata M., Ahmed A., Miura T., Takasu T., Kono R., Ogata T., et al. Seroepidemiological study of infection with West Nile virus in Karachi, Pakistan, in 1983 and 1985. J Med Virol 1988, 26:243-247.
5. Yu Y.X., Zhang G.M., Guo Y.P., Ao J., Li H.M. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 1988, 39:214-217.
6. Liu Z.L., Hennessy S., Strom B.L., Tsai T.F., Wan C.M., Tang S.C., et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis 1997, 176:1366-1369.
7. Tandan J.B., Ohrr H., Sohn Y.M., Yoksan S., Ji M., Nam C.M., et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 2007, 25:5041-5045.
8. Beasley D.W., Lewthwaite P., Solomon T. Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther 2008, 8:95-106.
9. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., Sohn Y.M., et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001, 358:791-795.
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
11. Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 2001, 14:495-498.
12. Ho L.J., Wang J.J., Shaio M.F., Kao C.L., Chang D.M., Han S.W., et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 2001, 166:1499-1506.
13. Raftery M.J., Kraus A.A., Ulrich R., Kruger D.H., Schonrich G. Hantavirus infection of dendritic cells. J Virol 2002, 76:10724-10733.
14. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A., et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999, 189:821-829.
15. Barba-Spaeth G., Longman R.S., Albert M.L., Rice C.M. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 2005, 202:1179-1184.
16. Li Y.M., Xu M., Chen L., Zhu J.H., Ye J., Liu X.Q., et al. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus. Vaccine 2009, 27:6004-6010.
17. Shameem G.M.M., Morita K., Haishi S., Igarashi A. Optimal conditions of plaque titration of Japanese encephalitis viruson BHK21 cells. Trop Med 1989, 31:151-159.
18. Aleyas A.G., George J.A., Han Y.W., Rahman M.M., Kim S.J., Han S.B., et al. Functional modulation of dendritic cells and macrophages by Japanese Encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol 2009, 183:2462-2474.
19. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nat Immunol 1998, 392:245-252.
20. Jessie K., Fong M.Y., Devi S., Lam S.K., Wong K.T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004, 189:1411-1418.
21. Wu S.J., Geraldine G.V., Wellington S., John R.M., Elena B., Ravithat P., et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000, 6:816-820.
22. Groot F., van Capel T.M.M., Kapsenberg M.L., Berkhout B., de Jong EC Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood 2006, 108:1957-1964.
23. Engering A., Geijtenbeek T.B., van Vliet S.J., Wijers M., van Liempt E., Demaurex N., et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002, 168:2118-2126.
24. Figdor C.G., van Kooyk Y., Adema G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002, 2:77-84.
25. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., Van G.C., Duijnhoven J., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
26. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003, 197:823-829.
27. Halary F., Amara A., Lortat-Jacob H., Messerle M., Delaunay T., Houles C., et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002, 17:653-664.
28. Lin G., Simmons G., Pöhlmann S., Baribaud F., Ni H., Leslie G.J., et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 2003, 77:1337-1346.
29. Pöhlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003, 77:4070-4080.
30. Lin C.W., Wu S.C. A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol 2003, 77:2600-2606.
31. Querec T., Bennouna S., Alkan K., Laouar Y., Gorden K., Flavell R., et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006, 203:413-424.
32. Lotz MK Cytokines and their receptors. Arthritis and allied conditions. Textbook of rheumatology 2001, 436-477. Lippencott Williams & Wilkins, Philadelphia, PA, USA. 14th ed. W.J. Koopman (Ed.).
33. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54:1-13.
34. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
35. Pollara G., Speidel K., Samady L., Rajpopatet M., Mcgrath Y., Ledermann J., et al. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J Infect Dis 2003, 187:165-178.
36. Mahanty S., Hutchinson K., Agarwal S., McRae M., Rollin P.E., Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 2003, 170:2797-2801.
37. Tuettenberg A., Jonuleit H., Tuting T., Jürgen B., Volker B., Stefan K., et al. Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): implications for immunotherapy using genetically modified DC. J Immunol 2004, 172:1524-1530.
38. Carrasco C.P., Rigden R.C., Vincent I.E., Balmelli C., Ceppi M., Bauhofer O., et al. Interaction of classical swine fever virus with dendritic cells. J Gen Virol 2004, 85:1633-1641.
39. Tavakoli S., Schwerin W., Rohwer A., Hoffmann S., Weyer S., Weth R., et al. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 2004, 85:2829-2836.
40. Longman R.S., Talal A.H., Jacobson I.M., Albert M.L., Rice C.M. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004, 103:1026-1029.
41. Iwashiro M., Messer R.J., Peterson K.E., Stromnes I.M., Sugie T., Hasenkrug K.J. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci USA 2001, 98:9226-9230.
42. Balkow S., Krux F., Loser K., Becker J.U., Grabbe S., Dittmer U. Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naïve T cells, and favors expansion of regulatory T cells. Blood 2007, 110:3949-3958.
43. Barboza L., Salmen S., Goncalves L., Colmenares M., Peterson D., Montes H., et al. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 2007, 368:41-49.
44. Kinter A., McNally J., Riggin L., Jackson R., Roby G., Fauci A.S. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci USA 2007, 104:3390-3395.
45. Pereira L.E., Villinger F., Onlamoon N., Bryan P., Cardona A., Pattanapanysat K., et al. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J Virol 2007, 81:4445-4456.
46. Roncarolo M.G., Levings M.K., Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 2001, 193:F5-F9.
47. Andersen M.M., Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet 1991, 337:1044.
48. Nothdurft H.D., Jelinek T., Marschang A., Maiwald H., Kapaun A., Loscher T. Adverse reactions to Japanese encephalitis vaccine in travellers. J Infect 1996, 32:119-122.